Teva's Deal-Making Spurs Inflows To Israel ETFs

By: via Benzinga
Israel-based Teva Pharmaceuticals (NASDAQ: TEVA) last week said it will pay $40.5 billion for Allergan(NYSE: AGN)'s generic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.